PTC Therapeutics Stock Target Price and Analyst Consensus
| PTCT Stock | USD 54.24 0.75 1.36% |
The current analyst and expert consensus on PTC Therapeutics is Buy, with 1 strong sell and 6 strong buy opinions. The current projected PTC Therapeutics target price consensus is 58.36 with 15 analyst opinions. Check out Macroaxis Advice on PTC Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.The most common way PTC Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview PTC Therapeutics executives and customers to further validate their buy or sell advice. PTC Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected PTC Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 2.5684.
Lowest Forecast 53.1 | Highest Forecast 64.78 | Target Price 58.36 |
PTC |
It's important to approach PTC Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
PTC Therapeutics Target Price Consensus
PTC target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. PTC Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 15 | Buy |
Most PTC analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand PTC stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of PTC Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPTC Therapeutics Target Price Projection
PTC Therapeutics' current and average target prices are 54.24 and 58.36, respectively. The current price of PTC Therapeutics is the price at which PTC Therapeutics is currently trading. On the other hand, PTC Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
PTC Therapeutics Market Quote on 28th of March 2025
Target Price
Analyst Consensus On PTC Therapeutics Target Price
PTC Therapeutics Analyst Ratings
PTC Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about PTC Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of PTC Therapeutics' financials, market performance, and future outlook by experienced professionals. PTC Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize PTC Therapeutics price targets
PTC Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using PTC Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at PTC Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if PTC Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional PTC Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of PTC Therapeutics is a key component of PTC Therapeutics valuation and have some predictive power on the future returns of a PTC Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PTC Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Cancer Fighters Invested over 90 shares | |
 | Air Invested over 400 shares | |
 | Macroaxis Index Invested over 200 shares | |
 | Compulsion Invested over 20 shares | |
 | Precious Metals Invested over 100 shares | |
 | Investor Favorites Invested over 300 shares | |
 | Momentum Invested few shares | |
 | Blockchain Invested few shares | |
 | Business Services Invested few shares | |
 | Driverless Cars Invested over 300 shares | |
 | Hedge Favorites Invested over 60 shares |
Additional Tools for PTC Stock Analysis
When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.